Abstract
Adjuvants may be the key to designing vaccines with increased immunogenicity without increasing the dosage of immunogen. Cytokines, saponins, mutant enterotoxins and monophosphoryl lipids are some of the agents being developed as adjuvants for use in vaccines against cancer and infectious diseases. The findings of preclinical investigations with these molecules were presented at the IBC 2nd Annual Conference on ‘New Advances in Vaccine Technologies and Applications’ [Bethesda, US; February 1995].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
